Four-Feature AND-Gate Cancer Selectivity: A Framework for Early-Stage Cancer Interception via Mesoporous Silica Nanoparticle Delivery

This hypothesis paper proposes a four-feature AND-gate cancer selectivity framework requiring four independent biological features—phosphatidylserine exposure, Thomsen-Friedenreich antigen expression, elevated reactive oxygen species, and active telomerase—to be satisfied simultaneously for cytotoxic activation. Implementation via mesoporous silica nanoparticle platform with bispecific PSBP-6/JAA-F11 surface targeting, CD47 mimetic anti-phagocytic protection, ROS-cleavable linker, and telomerase-responsive DNA hairpin payload uses substantially established chemistry. The framework extends recent work by Yilmaz et al. (2024) on phosphatidyl-conjugated telomerase-targeted cancer killing and Shi et al. (2018) on telomerase-responsive DNA hairpin release, integrating these with additional selectivity features through orthogonal biological dimensions. Coverage estimates of 63-80% across cancer types represent a deliberate selectivity-coverage trade-off favoring precision over breadth. The contribution is configurational rather than mechanistic, with explicit falsification conditions and acknowledged limitations including long-term safety unknowns and required chemistry development.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-05-21
DOI
https://doi.org/10.5281/zenodo.20328005
Primary Topic
RNA Interference and Gene Delivery
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Four-Feature AND-Gate Cancer Selectivity: A Framework for Early-Stage Cancer Interception via Mesoporous Silica Nanoparticle Delivery

JonPaul Womack
Zenodo (CERN European Organization for Nuclear Research)
RNA Interference and Gene Delivery
preprint

Four-Feature AND-Gate Cancer Selectivity: A Framework for Early-Stage Cancer Interception via Mesoporous Silica Nanoparticle Delivery

JonPaul Womack
preprint en

Abstract

This hypothesis paper proposes a four-feature AND-gate cancer selectivity framework requiring four independent biological features—phosphatidylserine exposure, Thomsen-Friedenreich antigen expression, elevated reactive oxygen species, and active telomerase—to be satisfied simultaneously for cytotoxic activation. Implementation via mesoporous silica nanoparticle platform with bispecific PSBP-6/JAA-F11 surface targeting, CD47 mimetic anti-phagocytic protection, ROS-cleavable linker, and telomerase-responsive DNA hairpin payload uses substantially established chemistry. The framework extends recent work by Yilmaz et al. (2024) on phosphatidyl-conjugated telomerase-targeted cancer killing and Shi et al. (2018) on telomerase-responsive DNA hairpin release, integrating these with additional selectivity features through orthogonal biological dimensions. Coverage estimates of 63-80% across cancer types represent a deliberate selectivity-coverage trade-off favoring precision over breadth. The contribution is configurational rather than mechanistic, with explicit falsification conditions and acknowledged limitations including long-term safety unknowns and required chemistry development.

Zenodo (CERN European Organization for Nuclear Research)
RNA Interference and Gene Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.